GPT and metabolic dysfunction-associated steatotic liver disease: miR-223KO mice developed a full spectrum of nonalcoholic fatty liver disease (NAFLD) and more severe NASH phenotypes, as corroborated by higher levels of serum alanine aminotransferase (ALT), greater liver infiltration and fibrosis, and increased mRNA levels of pro-inflammatory cytokines.